April 24, 2025 April 24, 2025Categories From the Co-ChairsFrom the Co-Chairs, April 2025An update on the Group's activity; a new Central Biorepository and Pathology Facility director; a preview of key Group Meeting sessions
April 24, 2025 April 24, 2025Categories Active Clinical TrialsAmended Trial: Gelareh Sadigh and Ilana Graetz Give an Update on the EAQ221CD/CONCURxP Trial for Patients with Breast CancerThe changes broaden eligibility for this cancer care delivery study, which aims to improve medication adherence for patients with breast cancer
April 24, 2025 April 24, 2025Categories Active Clinical TrialsTrial Spotlight: A Closer Look at ECOG-ACRIN’s Studies for Adolescents and Young Adults with CancerThese two trials are open and enrolling adolescent and young adult survivors and patients with cancer
April 24, 2025 April 24, 2025Categories Institution SpotlightsInstitution Spotlight: Stanford Cancer InstituteA Standing Main Member of ECOG-ACRIN since 1990
April 24, 2025 April 24, 2025Categories Trial ResultsTrial Results: ECOG-ACRIN Research Round-UpSummaries of recently published ECOG-ACRIN research results
April 24, 2025 April 24, 2025Categories News in BriefNews in Brief, April 2025Summaries and links to timely information about research results presented at medical meetings, recognition of research leaders, and more